myirislogo
23 November, 2014 12:44 IST
My Last 5 Scrips
Company BSE Price (Rs) % Chg
State Bank O 305.05 2.68
Hindalco In 160.15 3.42
Bhel 252.75 3.00
Tata Stl 462.70 0.89
Tata Motors 530.45 1.11
Clear All Clear Last
   
NSE Live
Nifty Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Nse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
BSE Live
BSE30 Live Prices
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Advances / Declines new
Index Weightage new
Exchange Holidays new
Bse Sectors new
Contribution To Index new
Bonus new
Rights new
Delisted-Shares new
Split of Value new
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
Watch
Sector Watch
Economy Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Research
Research Reports
Snapshot-Fresenius Kabi Oncology Limited
Fresenius Kabi Oncology Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:32545NSE:FKONCOBloomberg:FKOL@INReuters:FRES.BO
Market Lot: 1Face Value: 1ISIN Demat: INE575G01010
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
06-JUL-13 Fresenius Kabi Oncology announced on Friday that it has received a warning letter from US FDA, asking for certain other information and implementation of more corrective and preventive measures so as to avoid recurrence of deviations. 27-MAY-11 Fresenius Kabi Oncology today announced that the company to further leverage its R&D and manufacturing competencies by entering into contract R&D and manufacturing agreements with Fresenius K...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
  -
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)30-Sep-2013(6)31-Mar-2013 (12)31-Mar-2012 (12)
Net sales 1625.104962.464711.19
Other Income8.5818.0113.86
Total Income1633.684980.474725.05
Cost of goods sold2434.164532.994568.61
OPBDIT-800.48447.48156.44
PAT-399.95805.89509.51
Gross Block---
Equity capital158.23158.23158.23
EPS (Rs.)-5.093.22
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-15.42 - 34.5825.36 - 51.24
Debt / Equity (x)---
Operating margin (% of OI)-49.0 9.0 3.3
Net margin (% of OI)-24.516.210.8
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
B - 310, Som Datt Chambers - I
Bhikaji Cama Place
New Delhi
Delhi-110 066
PHONE
(011) 2610 5570
FAX
(011) 2619 5965
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer